Exploring Harm Reduction Advice for Prescription Stimulants on Reddit

Abstract

Psychostimulants such as amphetamine salts and methylphenidate are commonly prescribed for the treatment of attention deficit hyperactivity disorder (ADHD). However, their nonmedical use is also prevalent. Both medical and nonmedical use of these substances can lead to a range of side effects. Despite this, there is limited research on harm reduction strategies employed by users of prescription stimulants. This study, therefore aimed to explore the harm reduction strategies discussed by individuals using prescription stimulants on Reddit, to provide insights into how these strategies are shared and implemented. A multisite qualitative analysis was conducted on discussions from several subreddits, including r/ADHD, r/drugs, r/stims, and r/nootropics. The data were collected and analyzed to identify common themes and strategies related to harm reduction. Across all subreddits, individuals emphasized the importance of maintaining a balanced diet, engaging in regular exercise, staying hydrated, and practicing good sleep hygiene as crucial components of their harm reduction practices. Redditors on r/Drugs, r/Nootropics and r/Stims frequently recommended various substances to mitigate the side effects of stimulants. In contrast, r/ADHD focused more on consulting healthcare professionals and adjusting medication regimens. This study highlighted the significant role of online communities in sharing harm reduction strategies and supporting individuals in managing their stimulant use. This study provides important insights for healthcare professionals, including clinicians, alcohol and other drug counselors, mental health clinicians and general practitioners on how to offer better support and guidance for both medical and nonmedical use of prescription stimulants.

Keywords

Reddit ADHD psychostimulants harm reduction ADHD medication

This study investigates the harm reduction strategies that people who use prescription stimulants engage in to avoid or manage the side effects from their substance use.

Psychostimulants, such as amphetamine salts and methylphenidate, are commonly produced as prescription medication primarily for the treatment of attention deficit hyperactivity disorder (ADHD), due to their ability to reduce core symptoms of hyperactivity, impulsivity and inattention (Furman, 2005). Being the primary pharmacological treatment for ADHD (Kooij et al., 2019), the prevalence of medically used prescription stimulants is high, estimated at around 4.5% of the U.S. population (Compton et al., 2018). This rate has been estimated to have increased (Board et al., 2020), especially during and following the COVID-19 pandemic (Board et al., 2020; Chai et al., 2024).

Additionally, approximately 0.6% to 2% of U.S. adults report past-year nonmedical use of prescription stimulants—that is, use without being prescribed or taken differently than as prescribed (Compton et al., 2018; Faraone et al., 2020; Substance Abuse and Mental Health Services Administration, 2016). Qualitative investigation has found psychostimulants have been used amongst college students as cognitive enhancers because of their effect on memory, concentration and learning performance (Jensen et al., 2016). Additionally, individuals have reported increased energy and interest in learning after taking prescription stimulants, allowing them to work for long periods (Vrecko, 2013).The beneficial effects of prescription stimulants, however, also come with side-effects. Side-effects of prescription stimulants are extensive and include symptoms such as elevated blood pressure, irregular heartbeat, nausea, anxiety, insomnia, and decreased appetite (Weyandt et al., 2014). These side effects have been reported for both medical and nonmedical use (Smith et al., 2017). However, we know little about how people who use prescription stimulants seek to reduce the harms they experience from their use.

Previous research has investigated how people who use drugs have engaged in strategies to reduce their drug-related harm among people who inject drugs (Boucher et al., 2017; Nguyen et al., 2022), people who use opioids (Corser et al., 2022), and people who use MDMA (Sharifimonfared & Hammersley, 2020; Span et al., 2024) and methamphetamine (Wilkerson et al., 2015). Harm reduction strategies reported by participants in these studies included drug checking (Goldman et al., 2019), monitoring their use (Brunt, 2017), needle exchange and engaging in counseling (Gomes & Vecchia, 2018). However, despite their prevalent use, the evidence base about harm reduction is lacking among people who use prescription stimulants, with existing findings being isolated anecdotes, or found peripherally in the investigation of other aims (Aikins, 2012; Kecojevic et al., 2015; Silva et al., 2013). Additionally, there is a general lack of information online about harm-reduction measures individuals can use when taking these medications as prescribed. This is especially relevant as people who use stimulants as prescribed have been found to report side effects more frequently than people who use prescription stimulants nonmedically (Smith et al., 2017).

Understanding the real-world harm reduction practices of people who use drugs can be beneficial across a spectrum of professional settings. In this study, we focus on bottom-up harm reduction strategies, which refer to the self-initiated practices that individuals engage in to prevent or mitigate the harmful consequences associated with drug use (Allott & Redman, 2006). Examples of these strategies include monitoring dosage, engagement in community services and maintaining a healthy lifestyle (Boucher et al., 2017; Greenspan et al., 2011). We also adopt an expanded view of harm reduction that encompasses not only immediate, near-use risk-mitigation strategies, but also regular daily-living routines like self-care and healthy-lifestyle practices (sleep, nutrition, hydration, exercise; Boucher et al., 2017; Hardon & Hymans, 2016) because they may mitigate stimulant-related harms over time.

These practices reflect the agency and self-care practices of individuals who use drugs, emphasizing their active role in managing their health and well-being (Boucher et al., 2017; Drumm et al., 2005). They are distinct from top-down interventions, which are typically delivered by institutions or professionals (Span et al., 2024).

Prior research has documented bottom-up harm-reduction practices generated and circulated by people who use drugs. A Contemporary Drug Problems special issue on “harm reduction from below” (Hardon & Hymans, 2016) highlighted the wealth of community practices for reducing risk (Van Schipstal et al., 2016), and the production and circulation of drug knowledge in online environments (Berning & Hardon, 2016; Boothroyd & Lewis, 2016). Positioning our multisite Reddit analysis alongside this literature clarifies that the strategies described in our material reflect established community practices and extend them to prescription-stimulant contexts.

Alcohol and other drug counselors can better support individuals who use stimulants nonmedically, offering targeted advice on minimizing risks. Mental health clinicians, general practitioners, and other substance use professionals can apply these findings to improve patient care and support, acknowledging the diverse ways individuals use and manage their stimulant use.

The goal of the present study was to qualitatively explore the self-reported experiences and harm reduction strategies described by people who use prescription stimulants The research question guiding this study was how do individuals who use prescription stimulants describe and engage in bottom-up harm reduction strategies?

To investigate this, we collected and analyzed social media data (Reddit), an avenue that has been increasingly used in substance use research to understand the behaviors of individuals (Chi & Chen, 2023). Social media offers a unique opportunity to access naturally occurring data, where individuals may openly discuss their nonmedical prescription drug use in ways they are often unwilling to disclose to healthcare professionals (Ali & LoveJennifer, 2022; Kim et al., 2017). Therefore, this study will analyze this discussion qualitatively to explore the nuanced, bottom-up harm reduction strategies employed by individuals who use prescription stimulants.

Method

Site Selection

Reddit is the largest online English forum board, with over 52 million daily users (commonly referred to as redditors; Patel, 2020). Reddit is comprised of thousands of content-specific digital communities known as subreddits. Many of these subreddits contain discussions related to the use of prescription stimulants, each varying in their purpose and content. For example, the subreddit r/ADHD focuses on the experiences of those with ADHD, while r/drugs focuses more on nonmedical use. This diversity allows us to capture a broad spectrum of harm reduction strategies related to prescription stimulant use. To capture a diversity of experiences, we employed a multisite framework, analyzing discussions from a series of subreddits (r/ADHD, r/drugs, r/stims, and r/nootropics).

This study drew from discussion on the subreddits r/ADHD, r/Nootropics, r/Stims and r/Drugs. The largest subreddit, r/ADHD (1.5 million redditors), discusses the experiences of those who have ADHD. The subreddit provided a useful avenue for examining the experience of stimulant use among those prescribed the medication. Additionally, discussion of stimulants on the subreddit r/nootropics (340 k redditors), which discusses cognitive enhancers, was also included. Posts from the subreddit r/drugs, which has 916 k members and is dedicated to discussions on all substances, as well as from r/stims, which has 116 k members and focuses specifically on stimulants, were also examined. This selection of subreddits was expected to show the diversity of experiences of individuals who take stimulants.

This research received an ethics exemption from the University of Queensland Human Research Ethics Committee (2022/HE001469) because it did not include human participants and used publicly available data. Prior to examining the posts, the authors contacted the moderators of each subreddit informing them of the aims of the research. However, no response was received. Our use was compliant with Reddit's conditions of access at the time which stated permission is not required from Reddit to use their Application Programming Interface (API) for noncommercial use. To protect individuals’ identities, comments were obscured so they would remain unsearchable. This was done by amending grammar and spelling errors and removing irrelevant sections. Reverse search checks were employed to verify deidentification.

Data Collection

The subreddit-comments-dl (pistocop, 2022) tool was used to extract submissions made to these subreddits. This script retrieves the submission IDs for posts using the Reddit API search optimizer, pushshift.io, before extracting its content using the Python Reddit API Wrapper package.

Extractions were done between July 26th and 28th, 2022. To ensure a representative sample of discussions, we scraped a large number of posts from each subreddit: r/ADHD (n = 11,992), r/stims (n = 11,985), r/drugs (n = 11,997), r/nootropics (n = 11,984). These posts were collected chronologically and ranged between May 15th, 2021 and July 25th, 2022, as well as comments from these posts.

To filter out irrelevant discussion, a list of keywords was developed to search for posts about prescription stimulant use. This list included both the generic and brand names of prescription stimulants. These terms were then manually searched on each subreddit to remove those that resulted in no relevant posts. The full list of keywords can be seen in Supplemental Materials A.

Each subreddit was searched independently using R. Posts were included if they contained relevant terms in either the title or body text. The number of posts included varied between subreddits. For r/ADHD, 9.15% (n = 1,097) contained keywords; for r/stims, 20.77% (n = 2,487), for drugs 6.26% (n = 751) and for r/nootropics 3.21% (n = 385).

The remaining posts were then manually screened. Posts were included if they were English text-based posts related to prescription stimulants. Posts about nonpharmaceutically produced stimulants were excluded. We also excluded posts that were deleted by the poster or removed by moderators. Additionally, joke and parody posts, posts with no text (photos/videos only), and posts with less than 25 characters were removed. Inclusion rates and characteristics of included posts can be seen in Table 1.

Table 1.

Characteristics of Included Posts for Each Subreddit.

Subreddit	Total	Included	Excluded	Inclusion %	Comments	Avg. upvotes	Comments	Com. analyzed*
r/Nootropics	385	47	338	12.2	2221	46.57	2221	1460
r/ADHD	1098	238	860	21.7	4704	7.81	563	563
r/Stims	2488	453	2035	18.2	7497	8.18	558	558
r/Drugs	752	140	612	18.6	1626	6.00	743	706
Total	4723	878	3845	18.6	16,048	17.14	4085	3287

*For threads with over 100 comments, only the top 100 upvoted were included in analysis.

Randomization was conducted in R by shuffling the eligible posts from each subreddit using the sample function and selecting the first 50 for analysis. For r/nootropics, only 47 eligible posts remained after screening, so all were included. Posts were then merged with their associated comments. For highly replied threads, we collected the top 100 most upvoted comments to ensure the most representative viewpoints were captured. This was to prevent the discourse from being dominated by a few extensive threads while still ensuring a diverse representation of community perspectives and focusing on the most valued insights. These were converted into text files and imported into NVivo 12 for qualitative analysis.

Data Analysis

For analysis, we adapted guidelines from Jenkins et al. (2018) on multisite qualitative analysis (MSQA). MSQA utilizes a three-stage approach, where data are analyzed within-site, between-sites and within-site again. This approach allows us to examine the similarities and differences between discussions on the subreddits.

The first stage was within-site analysis, where discussion on each subreddit was analyzed separately. The thematic analysis approach outlined by Braun and Clarke (2006) was used to explore these discussions. Initial stages of analysis were conducted by a single coder (BJ). This began with the coder reading the dataset and noting initial impressions. After familiarization, the coder reexamined the data and the coding process began. The initial coding process was conducted by BJ without any predefined codes or themes, to capture emerging and novel insights present in the dataset. This meant actively engaging with the content to highlight emerging patterns, unique insights, and novel observations regarding individuals harm reduction behaviors. Collaboratively with another researcher (NT), the coded data were then collated into preliminary themes based on their similarity. Topics that were recurrent and held significant meaning within the dataset were coded. These themes were then reviewed and labeled. This process was repeated for all subreddits.

Following this, results were compared between sites (i.e., across subreddits). In this stage, we contrasted the themes from each subreddit to identify how harm reduction discussion varied and converged across online communities. This allowed us to identify patterns present across the entire dataset which informed the development of the overarching themes (Jenkins et al., 2018).

This stage was followed by a final within-site analysis, where the subreddits were reexamined independently to assess the suitability of the overarching themes and identify site-specific elements. Threads were then recoded deductively based on the finalized themes. The process also involved counting how often these themes appeared in posts across each subreddit. Additionally, for the theme “Use of Additional Substances,” the frequency of mentions for various substances was counted and categorized by subreddit.

Results

Harm reduction posts across the subreddits were primarily centered on providing practical advice, sharing personal experiences, and offering support to others. Redditors often engaged in discussions to suggest strategies for mitigating the adverse effects of prescription stimulant use, emphasizing a community-driven approach to managing their health. These posts included a wide range of recommendations. Through detailed exchanges, redditors created a collaborative environment where harm reduction strategies could be explored and refined. This analysis uncovered four specific themes: the use of additional substances, achieving a healthy lifestyle, consulting with healthcare professionals, and strategies for reducing stimulant use. The final themes can be seen in Table 2.

Table 2.

Themes Overview With Frequency.

Themes (number of threads discussing themes)	Threads in each subreddit	Description	Subthemes
Use of additional substances (n = 41)	r/ADHD = 3 r/Nootropics = 18 r/Drugs = 9 r/Stims = 11	Discussing the use of additional substances to manage side effects prescription stimulants.	Use of depressants to reduce stimulant comedown Supplementation with vitamins and/or minerals to improve health Use of substances to reduce tolerance to stimulants Recommendation to avoid certain drug interactions
Healthy lifestyle (n = 24)	r/ADHD = 10 r/Nootropics = 2 r/Drugs = 5 r/Stims = 7	Discussing ways to maintain a healthy lifestyle while using stimulants.	Suggestions regarding eating or diet Suggestions regarding hydration Exercise Sleep hygiene strategies
Talk to doctor (n = 14)	r/ADHD = 10 r/Nootropics = 2 r/Drugs = 1 r/Stims = 1	Emphasizing the importance of consulting healthcare professionals about stimulant use and side effects.	Encouragement to ask doctor about side effects of substance Keep journal of medication effects Reassurances that it takes time to find right treatment Suggestion to request change in dosage or medication type
Reducing use (n = 16)	r/ADHD = 0 r/Nootropics = 2 r/Drugs = 5 r/Stims = 9	Encouraging others to reduce or stop stimulant use.	Recommendations to reduce use or stop altogether Warnings of consequences of stimulant use

Use of Additional Substances

Redditors frequently discussed substances they used or recommended to help manage the side effects. Most frequently, discussions were in reply to other redditors asking about the suitability of certain substances. On r/Nootropics, which contained the majority of substance discussions (n = 18), the use of other substances, from pharmaceutical drugs to over-the-counter supplements, were regularly given as general harm reduction advice. Redditors posting in r/drugs (n = 9) and r/stims (n = 11) also discussed reducing harm through the use of drugs, although the variety of substances recommended and consumed were not as wide or prevalent as featured on r/Nootropics. Discussion of additional substances for harm reduction on r/ADHD was limited (n = 3). However, some redditors recommended talking with their doctor about a medication that may help.

Redditors would typically share their thoughts on the substance, often based on their previous experiences. Some posters also linked research to support their position. When providing recommendations, posts would often describe what the substance does, instructions on dosage and unsafe interactions.

Overall, 31 substances were mentioned at least three times in discussions in the context of harm reduction. Full frequencies can be seen in Table 3.

Table 3.

List of Substances Mentioned for Harm Reduction at Least Three Times.

Substance	ADHD	Nootropics	Drugs	Stims	Total
Supplements
Magnesium	0	46	1	10	57
L-theanine	0	30	1	6	37
L-tyrosine	0	30	0	4	34
Vitamin B	4	11	6	6	27
Vitamin D	0	6	3	6	15
Omega-3	0	7	3	1	11
Vitamin C	0	8	0	2	10
GABA	0	1	1	7	9
Zinc supplements	0	5	1	0	6
Ginkgo biloba	0	6	0	0	6
Multivitamin	0	1	0	3	4
Stimulants
Caffeine/coffee	11	21	16	24	72
Racetam	0	6	2	3	11
Clobenzorex	0	0	0	4	4
Nootropics
NAC (N-acetylcysteine)	0	63	0	2	65
Agmatine	0	24	0	5	29
Racetam	0	16	2	3	21
Phenibut	0	16	0	0	16
Memantine	0	10	0	0	10
NALT	0	6	0	0	6
L-Dopa	0	6	0	0	6
Ginseng root	1	4	0	0	5
Magnolia bark	0	3	0	0	3
Depressants
Xanax	0	20	31	11	62
Weed/cannabis	0	18	26	9	53
Alcohol	0	6	20	10	36
Valium	0	11	9	7	27
Diazepam	1	8	10	2	21
Klonopin	0	12	3	1	16
Kratom	0	5	5	1	11
Opiates	0	3	2	3	7

Depressants such as alcohol, cannabis and benzodiazepines were frequently discussed for their ability to reduce anxiety and physical discomfort following stimulant use. Redditors also found these drugs helpful to aid eating and sleeping. This was usually following recreational use involving high dosages. Benzodiazepines, especially Valium and Xanax, were the most frequently mentioned, especially on r/drugs and r/stims. Many reported taking benzodiazepines during the stimulant's active effect or on the comedown to reduce physical effects of anxiety and jitteriness:

I would save the benzos for when you really need them with the addy. Like to relax so you can sleep or to sleep. Or only when you feel you are experiencing uncomfortable physical anxiety (r/Drugs).

Another commonly discussed option was caffeine. The effects of this substance varied between individuals, with some redditors finding it generally useful for mitigating the negative side effects associated with the “crash” experienced after stimulant medication wears off. Some users reported that caffeine helped reduce symptoms like irritability and fatigue, which often accompany the crash. For example, one redditor stated:

I’m on 30 mg Vyvanse now and the crashes can be subdued with coffee … My crashes on adderal are a lot more subtle (irritability only, no dark thoughts, no hopelessness) (r/ADHD).

Also commonly recommended were vitamin and mineral supplements, most commonly Vitamin B, D and fish oils. These were recommended to improve general health whilst taking stimulants and reduce side effects. Magnesium supplementation was also recommended and used widely as a harm reduction strategy for many purposes, primarily as a muscle relaxant to help with physical side effects such as muscle cramping and jaw clenching. It was also recommended as helpful for insomnia:

I took magnesium glycinate at night when I took Adderall and it helped me get an awesome night's sleep (r/Drugs).

Redditors on r/Nootropics also frequently discussed alternative substances for harm reduction purposes. These substances rarely featured in discussion in other subreddits. Individuals on r/Nootropics would often report experimenting with a variety of substances and share detailed information about their effects, including their capabilities to reduce side effects and increasing overall well-being:

L-Theanine helps reduce anxiety brought on by stimulants. Sabroxy can potentiate them and Skullcap can help smooth out the crash in the afternoon. Lemon Balm, GABA, Magnolia Bark, and Mulungu help sleep at night (r/Nootropics).

Redditors also discussed substances that would help them alleviate the long-term effects of stimulant use. The most commonly discussed substance was N-acetylcysteine (NAC), which featured nearly exclusively on r/Nootropics. Individuals heavily promoted NACs ability to reduce stimulant tolerance, allowing redditors to get intended effects on lower dosages. NAC was also heavily promoted as an aid for recovery from adverse effects of long-term stimulant use, mainly anhedonia and emotional blunting:

I was getting bad side effects from methylphenidate and took NAC. I was surprised by how quickly and how much the side effects went away (r/Nootropics).

Achieving a Healthy Lifestyle

Individuals across all subreddits discussed the importance of healthy living on their overall health and reducing long-term damage from stimulants. This discussion was especially common in r/ADHD (n = 10), but also featured in r/drugs (n = 5), r/stims (n = 7), and r/Nootropics (n = 2). Many redditors felt that stimulants impaired their ability to live healthily. The wakefulness and appetite-suppressing effects of stimulants reportedly impeded redditors’ ability to achieve adequate sleep and nutrition. Additionally, redditors often forgot to hydrate, which they felt was harmful to their health and led to worse side effects. To mitigate these side effects, redditors discussed and recommended various healthy living strategies. To combat the wakefulness effects, redditors recommended taking medication early in the day to avoid sleep disruption. Good sleep hygiene strategies, especially sunlight exposure upon waking, were also suggested. Exercise was recommended to help tire the body, aiding with sleep and reducing the comedown effects, for example:

Exercise is just as important as water or diet to make sure you’re letting [your]you’re body metabolize your meds (r/ADHD).

To navigate appetite suppression, redditors suggested eating large, high-protein meals before taking stimulants to reduce blood sugar fluctuations. Regular snacking throughout the stimulants’ active dose was also recommended. In r/ADHD, redditors frequently set alarms to remind themselves to eat and hydrate. One redditor shared:

Big protein-focused breakfast and set an alarm to remind myself to eat lunch! … Dinner a meat and a veggie. I avoid sugar and limit carbs! (r/ADHD).

Some redditors recommended drinking water at a higher rate than usual due to the dehydrating effects of stimulants. Along with water, electrolyte drinks were also suggested. One redditor advised:

Keep electrolyte drinks on hand and drink them regularly. Amphetamines deplete them incredibly fast (r/Stims).

Consulting a Doctor

Individuals who were prescribed stimulants and experiencing adverse effects were often encouraged to consult their doctor about these side effects. This was most common on r/ADHD (n = 10), where individuals were taking medication as per their doctor's instruction. There were also discussions in r/Nootropics (n = 2), r/drugs (n = 1), and r/stims (n = 1). Many suggested checking with their doctor to determine if the side effects were normal and what steps to take to address them:

But, you should always consult your doctor if you have concerns about your meds. They know what they are doing and together you can find a treatment plan that works for you (r/ADHD).

Several redditors suggested keeping a journal to record the effects of the medication. This was so individuals could provide their doctors with valuable information to make informed decisions about their treatment:

Keep up with the doctor, keep notes of how you feel, how they’re working and not working. It's normal to need med and dose changes (r/ADHD).

Some redditors suggested that a change in dosage or medication type may be helpful for alleviating their symptoms:

I didn’t tolerate Adderall at first but was switched to Vyvanse and now handle it much better (r/ADHD).

Reducing use

The frequency and dosage of stimulant use, especially among those unprescribed, were regularly discussed and scrutinized by other individuals in the community. Under posts describing side effects from stimulant use, other individuals would commonly recommend reducing use or stopping altogether. These recommendations were typically found in r/drugs (n = 5) and r/stims (n = 9), where self-described periods of bingeing were more frequent. There were also some discussions in r/Nootropics (n = 2), but none in r/ADHD.

To encourage others to reduce their use, some individuals shared their struggles with dependence. One individual shared:

I just lost everything to amphetamine addiction. … Your health, your sleep, your relationships with anyone and everyone, your job, your financial independence (that one is tough) and if you really go overboard potential lifelong consequences to your physical and mental health (psychosis, movement disorders, cognitive deficits etc…). I don’t know how to convey this next part but I will try. I was right where you are, right now, about a year ago (r/Stims).

Individuals typically referenced the potential damage of excessive stimulant use to physical and mental health. They highlighted the risk of changes to brain function, which could lead to long-term consequences such as anhedonia and emotional instability. One individual cautioned:

You are burning dopamine receptors already at these doses. I would try to lower it to once a week but I can see you are hooked. Lack of dopamine will punish you later. Have that in mind. You are entering a slippery slope (r/Stims).

Some individuals encouraged others to seek support, emphasizing the importance of getting professional support to manage their dependence. One noted:

All you can do is stay strong, get the right help and support, and definitely get rid of all the medications or you will be spending hours turning the house upside down looking for that one pill. Good luck; like any addiction, it's a lifetime of staying in control (r/Drugs).

These individuals often emphasized taking time off to allow the body to recover. One individual advised:

Get off the stims, sleep for a month and a half if you have to. It will help with the anhedonia and to repair the dopaminergic system (r/Stims).

Discussion

The purpose of this study was to capture the diverse use of prescription stimulants described on Reddit and identify the broad spectrum of harm reduction strategies discussed. These findings provide insights into how individuals who use prescription stimulants seek to reduce their experience of harm from taking prescription stimulants. The desire for people who use drugs to actively consider and care for their health and well-being has been found broadly in qualitative research (Boucher et al., 2017; Drumm et al., 2005). This study adds previously unreported details about individuals who, while planning to continue using prescription stimulants, actively discuss and implement harm reduction strategies. This study extends prior harm-reduction literature on other substances by detailing how individuals who actively use and plan to continue use prescription stimulants, actively discuss and implement harm reduction strategies. Our study adopted a unique approach, adapting methods from multi-site studies examining substance use behaviors (Jenkins et al., 2017, 2021), by treating subreddits as analogous to physical locations. This framework allowed us to assess a wide range of redditors’ experiences with prescription stimulants. It was found that harm reduction recommendations differ between online locations, similar to differences in physical locations found in multi-site studies (Jenkins et al., 2017). These online communities all had separate purposes and contained distinct norms and rules that served as the context in which discussion took place (Charach et al., 2004; Ivaturi & Chua, 2019). This influenced the type of content on each subreddit, with some harm reduction practices absent altogether in some subreddits.

Contextual variation across subreddits is also evident in prior Reddit-based research: drug forums function as peer information hubs circulating practical “how-to” guidance, self-medication narratives, and contested claims, but the content shifts with substance and setting. For example, microdosing threads centered on perceived benefits of use while also flagging adverse effects and dependence concerns, with discussion heavily oriented toward “how-to” advice (Lea et al., 2020; Pop et al., 2024). By contrast, in opioid-recovery communities, psychedelics were framed primarily around its use for harm reduction, providing withdrawal relief and craving reduction (Krawczyk et al., 2025). Our findings show a similar process with content varying heavily based on the subreddits purpose and norms. Together, this supports a multisite lens and the value of synthesizing across contexts when interpreting harm-reduction discussion (LeCocq et al., 2020).

Digital communities on platforms like Reddit not only provide a space for discussion but also serve as essential resources where individuals engage actively in exchanging detailed harm reduction advice. This is particularly significant given the accessibility and anonymity these platforms offer, allowing redditors to seek and share information that might be unavailable or stigmatized in more traditional health promotion settings. Studies suggest that the Internet is often the primary source for adolescents learning about harm reduction (Jakub et al., 2022), emphasizing the need to ensure the reliability of the information shared. For instance, “learning how to use drugs more safely” is a commonly given reason for visiting online drug forums (Chiauzzi et al., 2013), highlighting these platforms’ potential role in promoting safer drug use practices.

Additionally, our findings align with existing literature on harm reduction practices broadly. Redditors widely recommended maintaining a healthy lifestyle, including regular exercise, a balanced diet, and adequate hydration, to mitigate the side effects of stimulant use, which is consistent with harm reduction strategies identified in studies on other substance use contexts (Drumm et al., 2005; Duterte et al., 2001; Span et al., 2024).

At the same time, “healthy lifestyle” recommendations mirror broader norms about what counts as a good or healthy life and emphasize individual responsibility, with limited attention to social supports, service access, and wider social and structural conditions that shape what is viable. This pattern has been noted in sociological work showing that harm-reduction discourse can be empowering while also shifting focus away from structural conditions (Moore & Fraser, 2006). In the material analyzed, online communities generated pragmatic, bottom-up harm-reduction strategies that were often useful while also reproducing prevailing assumptions and ideals. This underscores that individually focused practices are only one component of harm reduction and that complementary efforts such as advocacy for service availability, low barrier clinical support, and policy reform are also required to reduce harm to individuals who take drugs.

On platforms like r/drugs and r/stims, where higher dosages and prolonged usage of stimulants were often discussed, community members regularly advocated for reducing or ceasing use when discussing the negative side effects encountered. These types of recommendations were particularly prevalent in discussions involving significant use, reflecting a community-driven approach to managing potential risks associated with nonmedical stimulant use.

Additionally, for nonmedical use, redditors regularly described regulating use to reduce long-term adverse effects, which are also described in qualitative studies (Boucher et al., 2017; Drumm et al., 2005). Reduction strategies such as setting definitive limits and using substances in moderation are standard practices identified in harm reduction research (Fernández-Calderón et al., 2014; Jakub et al., 2022). This selective reduction approach becomes even more pertinent among redditors who have either witnessed or personally experienced the detrimental effects of substantial stimulant use, motivating them to adjust their behavior to minimize these risks (Jenkins et al., 2017).

The use and recommendation of various supplements by redditors to counteract adverse effects of prescription stimulants mirror similar recommendations found in other drug-use contexts (Boileau-Falardeau et al., 2022; Valente et al., 2020). These findings align with harm reduction strategies observed in studies in other stimulants, with combinations of stimulants such as cocaine and methamphetamine found to be frequently combined with a depressant to either calm down, induce sleep, alleviate anxiety or distress (Motta-Ochoa et al., 2017; Oliveira et al., 2010; Rigg & Ibanez, 2010). This may explain the high rate of polysubstance use among people who use nonmedical prescription stimulant (Chen et al., 2014), especially alcohol, cannabis and pain relievers.

This study also found a variety of other substances that individuals used to reduce side effects, which are not commonly found in the harm reduction literature, such as NAC and L-Theanine. NAC has been explored for its use in reducing methamphetamine dependence with limited success (McKetin et al., 2019). However, individuals mainly recommended it for reducing stimulant tolerance, allowing individuals to get the intended effects on lower dosages. NAC was also heavily promoted as an aid for recovering from adverse effects of long-term stimulant use, mainly anhedonia and emotional blunting. Additionally, the use of substances such as vitamins and magnesium for harm reduction purposes were frequently discussed, even though they have been previously unexplored in harm reduction research. Individuals praised the benefits of magnesium for reducing comedown problems such as sleep issues and cramps. Magnesium has been found to have benefits for neuromuscular relaxation (Ghodraty et al., 2012), which may counteract muscle tension and cramps experienced as side effects of stimulant medications. It may also improve sleep quality by activating the parasympathetic nervous system, promoting relaxation and helping redditors fall asleep more easily and maintain deeper sleep (Kawano et al., 1998).

These recommendations were mainly found on r/Nootropics, which is a subreddit containing lots of discussion of unconventional substances. This further shows the impact that the culture and purpose of an online community have on the type of harm reduction strategies employed, emphasizing the importance of exploring a diverse range of domains when investigating this issue.

Clinicians should recognize the extent to which people taking prescription stimulants think about, plan, and trial strategies to manage side effects; for many, these effects shape day-to-day routines. Routine care should explicitly ask about self-directed practices (sleep, nutrition, hydration, supplements, dose timing) and discuss safety and evidence. This matters for treatment persistence, with adverse effects commonly driving ADHD-medication discontinuation (Gajria et al., 2014). Our study shows that individuals typically describe guidance from healthcare providers as their primary strategy to deal with harm from taking prescription stimulants, underscoring the importance of having informed healthcare providers. This demonstrates the critical role of clinicians in reducing harm and understanding the strategies that individuals may be engaging in to mitigate these effects.

Future research needs to consider the overall effectiveness of these harm reduction strategies for individuals using prescription stimulants. Specifically, it is important to assess the efficacy and interactions of various substances used for harm reduction, such as vitamins and magnesium, with other medications. Understanding these interactions and their long-term health impacts is crucial for developing comprehensive harm reduction guidelines.

Additionally, research should identify which harm reduction strategies are effective for different types of prescription stimulant use, whether medical or nonmedical. This distinction is essential for providing tailored harm reduction approaches that address the specific needs of each group.

Limitations

These findings should be interpreted within the context of the study limitations. The generalizability of results is limited by the characteristics of the sample and dataset. The demographics of the sample are unknown and were not analyzed in this study. The userbase of Reddit tends to skew toward younger males who are left-leaning (Barthel et al., 2024), which means this study may not capture experiences from individuals outside of these characteristics.

Additionally, redditors often choose to divulge only certain elements of their experiences. Information about individuals’ social and occupational environments and the circumstances surrounding their stimulant use were often not described, resulting in an incomplete picture of their overall experience and the full range of factors contributing to stimulant use and the harm reduction strategies individuals employ. The study was also unable to distinguish between medical and nonmedical use of prescription stimulants due to the ambiguity in the data, making it difficult to ascertain if there were any differences in harm reduction strategies for medical and nonmedical use.

Another limitation of this study is that findings are time-bound to the sampling window (May 2021–July 2022). Platform features, moderation practices, and participation patterns may have shifted since then, meaning that the dynamics captured here might not reflect the current state of Reddit discussions on stimulant use.

Our dataset comprised English-language discussions on four publicly accessible Reddit communities. Posts in other languages or in additional communities were not captured, which constrains the cultural and linguistic diversity of perspectives included. Furthermore, changes in subreddit moderation may shape what kinds of content are allowed or encouraged, potentially limiting the comparability of these findings to later or different contexts.

Finally, while we adapted multisite qualitative analysis to compare several Reddit communities, our study remains confined to a single platform. As such, it cannot be considered fully “multisited” in the broader sense. Future research could extend this approach by including data from other social media platforms (e.g., forums, X/Twitter, Discord) or from offline contexts, thereby offering a more comprehensive view of how prescription stimulant use and harm-reduction practices are discussed across distinct social and cultural sites.

Conclusion

Overall, the harm reduction strategies that individuals recommended to each other align with those observed with other substances. This study provides valuable insight into the role of social networks in sharing harm reduction strategies among individuals who take prescription stimulants. Through the comprehensive analysis of reported experiences and behaviors associated with the use of prescription stimulants, this study demonstrates the value that online forums, such as Reddit, offer for understanding substance use behaviors. These forums serve as dynamic platforms for individuals to share harm reduction practices related to prescription stimulant use and offer researchers a nuanced understanding of real-world substance use behaviors.

However, more research is needed to understand how these behaviors differ between individuals who take prescription stimulants medically and nonmedically, as this study was unable to clearly differentiate between the two groups. This distinction is crucial for developing tailored harm reduction strategies that address the specific needs of each group.

Supplemental Material

sj-docx-1-cdx-10.1177_00914509251395274 - Supplemental material for Exploring Harm Reduction Advice for Prescription Stimulants on Reddit

Supplemental material, sj-docx-1-cdx-10.1177_00914509251395274 for Exploring Harm Reduction Advice for Prescription Stimulants on Reddit by Benjamin Johnson, Natalie Thomas and Caroline Salom in Contemporary Drug Problems

Footnotes

ORCID iD

Benjamin Johnson

Ethics Approval and Consent to Participate

Consent for Publication

Consent for publication was not required as per the ethics committee as the data used in this study were publicly available on Reddit. However, all identifiable user information has been anonymized to protect privacy, following ethical guidelines for using data from online platforms.

Authors’ Contributions

B.J. was responsible for all stages of the study, including conception, data analysis, data collection, writing, and editing the manuscript. C.R. was responsible for the conception and editing of the manuscript. N.T. contributed to the conception, data analysis, supervision, and editing of the final manuscript.

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

Declaration of Conflicting Interests

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Data Availability Statement

The datasets used and/or analyzed during the current study are not publicly available due to privacy concerns but are available from the corresponding author on reasonable request.

Supplemental Material

Supplemental material for this article is available online.

Author Biographies

Benjamin Johnson is a PhD candidate currently holding an NHMRC Post-Graduate Research Scholarship. His research examines both the medical and non-medical use of prescription stimulants, with a particular focus on challenges arising from the ongoing stimulant shortage. Additionally, he is engaged and interested in interdisciplinary projects exploring the intersections of artificial intelligence, gaming, and cryptocurrency trading, contributing to a broader understanding of emerging trends at the nexus of digital innovation and public health.

Natalie Thomas is an adjunct research fellow at the Institute for Social Science Research. Natalie's background is in criminology, and her work focuses broadly on the intersections of health and justice and the application of social science research methods to program evaluation. She completed her PhD through the School of Criminology and Criminal Justice at Griffith University. Her research interests include alcohol and other drug regulation and policy, criminal justice policy and programs, qualitative and mixed methods research, program evaluation and evidence reviews.

Caroline Salom is an associate professor at the Institute for Social Science Research. Her work focuses on substance use, the associated social and health challenges people face, and the services intended to support people who experience these issues. In addition to research, she is an evaluation specialist, collaborating extensively across academia, government and service environments.

References

Aikins

R. D.

(2012). Academic performance enhancement drugs in higher education. University of California.

Ali

A.-G.

LoveJennifer

(2022). Large-scale social media analysis reveals emotions associated with nonmedical prescription drug use. Health Data Science, 12(1), 1–14. https://doi.org/10.34133/2022/9851989

Allott

Redman

(2006). Patterns of use and harm reduction practices of ecstasy users in Australia. Drug and Alcohol Dependence, 82(2), 168–176. https://doi.org/10.1016/j.drugalcdep.2005.09.009

Barthel

M. G.

Stocking

Holcomb,

Mitchell . (2024). 1. Reddit news users more likely to be male, young and digital in their news preferences. Pew Research Centre. https://www.pewresearch.org/journalism/2016/02/25/reddit-news-users-more-likely-to-be-male-young-and-digital-in-their-news-preferences/

Berning

Hardon

(2016). Educated guesses and other ways to address the pharmacological uncertainty of designer drugs: An exploratory study of experimentation through an online drug forum. Contemporary Drug Problems, 43(3), 277–292. https://doi.org/10.1177/0091450916662164

Board

A. R.

Guy

Jones

C. M.

Hoots

(2020). Trends in stimulant dispensing by age, sex, state of residence, and prescriber specialty—United States, 2014–2019. Drug and Alcohol Dependence, 217, Article 108297. https://doi.org/10.1016/j.drugalcdep.2020.108297

Boileau-Falardeau

Contreras

Gariepy

Laprise

(2022). Patterns and motivations of polysubstance use: A rapid review of the qualitative evidence. Health Promotion and Chronic Disease Prevention in Canada, 42(2), 47–59. https://doi.org/10.24095/hpcdp.42.2.01. Tendances et motivations associees a la polyconsommation de substances : une revue rapide des donnees qualitatives

Boothroyd

Lewis

(2016). Online drug scenes and harm reduction from below as phronesis. Contemporary Drug Problems, 43(3), 293–307. https://doi.org/10.1177/0091450916654266

Boucher

L. M.

Marshall

Martin

Larose-Hebert

Flynn

J. V.

Lalonde

Pineau

Bigelow

Rose

Chase

Boyd

Tyndall

Kendall

(2017). Expanding conceptualizations of harm reduction: Results from a qualitative community-based participatory research study with people who inject drugs. Harm Reduction Journal, 14(1), Article 18. https://doi.org/10.1186/s12954-017-0145-2

10.

Braun

Clarke

(2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101. https://doi.org/10.1191/1478088706qp063oa

11.

Brunt

(2017). Drug checking as a harm reduction tool for recreational drug users: Opportunities and challenges.

12.

Chai

Goyal

Woods

Song

Dal Pan

(2024). Trends in incident prescriptions for behavioral health medications in the US, 2018-2022. JAMA Psychiatry, 81(4), 396–405. https://doi.org/10.1001/jamapsychiatry.2023.5045

13.

Charach

Ickowicz

Schachar

(2004). Stimulant treatment over five years: Adherence, effectiveness, and adverse effects. Journal of the American Academy of Child & Adolescent Psychiatry, 43(5), 559–567. https://doi.org/10.1097/00004583-200405000-00009

14.

Chen

L.-Y.

Crum

R. M.

Martins

S. S.

Kaufmann

C. N.

Strain

E. C.

Mojtabai

(2014). Patterns of concurrent substance use among nonmedical ADHD stimulant users: Results from the national survey on drug use and health. Drug and Alcohol Dependence, 142, 86–90. https://doi.org/10.1016/j.drugalcdep.2014.05.022

15.

Chi

Chen

H. Y.

(2023). Investigating substance use via reddit: Systematic scoping review. Journal of Medical Internet Research, 25(1), e48905. https://doi.org/10.2196/48905

16.

Chiauzzi

Dasmahapatra

Lobo

Barratt

M. J.

(2013). Participatory research with an online drug forum: A survey of user characteristics, information sharing, and harm reduction views. Substance Use & Misuse, 48(8), 661–670. https://doi.org/10.3109/10826084.2013.800117

17.

Compton

W. M.

Han

Blanco

Johnson

Jones

C. M.

(2018). Prevalence and correlates of prescription stimulant use, misuse, use disorders, and motivations for misuse among adults in the United States. American Journal of Psychiatry, 175(8), 741–755. https://doi.org/10.1176/appi.ajp.2018.17091048

18.

Corser

Palis

Fleury

Lamb

Lock

McDougall

Mehta

Newman

Spence

Buxton

J. A.

(2022). Identifying behaviours for survival and wellness among people who use methamphetamine with opioids in British Columbia: A qualitative study. Harm Reduction Journal, 19(1), Article 46. https://doi.org/10.1186/s12954-022-00630-8

19.

Drumm

R. D.

McBride

Metsch

Neufeld

Sawatsky

(2005). “I’m a health nut!” Street drug users’ accounts of self-care strategies. Journal of Drug Issues, 35(3), 607–629. https://doi.org/10.1177/002204260503500311

20.

Duterte

O’Neil

McKearin

Sales

Murphy

(2001). Walking the tightrope: Balancing health and drug use. Journal of Psychoactive Drugs, 33(2), 173–183. https://doi.org/10.1080/02791072.2001.10400482

21.

Faraone

S. V.

Rostain

A. L.

Montano

C. B.

Mason

Antshel

K. M.

Newcorn

J. H.

(2020). Systematic review: Nonmedical use of prescription stimulants: Risk factors, outcomes, and risk reduction strategies. Journal of the American Academy of Child & Adolescent Psychiatry, 59(1), 100–112. https://doi.org/10.1016/j.jaac.2019.06.012

22.

Fernández-Calderón

Lozano-Rojas

Rojas-Tejada

Bilbao-Acedos

Vidal-Giné

Vergara-Moragues

González-Saiz

(2014). Harm reduction behaviors among young polysubstance users at raves. Substance Abuse, 35(1), 45–50. https://doi.org/10.1080/08897077.2013.792760

23.

Furman

(2005). What is attention-deficit hyperactivity disorder (ADHD)? Journal of Child Neurology, 20(12), 994–1002. https://doi.org/10.1177/08830738050200121301

24.

Gajria

Sikirica

Greven

Zhong

Qin

Xie

(2014). Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder - A systematic literature review. Neuropsychiatr Dis Treat, 10, 1543–1569. https://doi.org/10.2147/NDT.S65721

25.

Ghodraty

M. R.

Saif

A. A.

Kholdebarin

A. R.

Rokhtabnak

Pournajafian

A. R.

Nikzad-Jamnani

A. R.

Shah

Nader

N. D.

(2012). The effects of magnesium sulfate on neuromuscular blockade by cisatracurium during induction of anesthesia. Journal of Anesthesia, 26(6), 858–863. https://doi.org/10.1007/s00540-012-1439-x

26.

Goldman

J. E.

Waye

K. M.

Periera

K. A.

Krieger

M. S.

Yedinak

J. L.

Marshall

B. D.

(2019). Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: A qualitative study. Harm Reduction Journal, 16, 1–11. https://doi.org/10.1186/s12954-018-0276-0

27.

Gomes

T. B.

Vecchia

M. D.

(2018). Harm reduction strategies regarding the misuse of alcohol and other drugs: A review of the literature. Ciência & Saúde Coletiva, 23(7), 2327–2338. https://doi.org/10.1590/1413-81232018237.21152016

28.

Greenspan

N. R.

Aguinaldo

J. P.

Husbands

Murray

Sutdhibhasilp

Cedano

Lau

Gray

Maharaj

(2011). “It’s not rocket science, what I do”: Self-directed harm reduction strategies among drug using ethno-racially diverse gay and bisexual men. International Journal of Drug Policy, 22(1), 56–62. https://doi.org/10.1016/j.drugpo.2010.09.004

29.

Hardon

Hymans

T. D.

(2016). Guest editors’ introduction: Harm reduction from below (Vol. 43, pp. 191–198). Sage Publications Sage CA.

30.

Ivaturi

Chua

(2019). Framing norms in online communities. Information & Management, 56(1), 15–27. https://doi.org/10.1016/j.im.2018.05.015

31.

Jakub

Krzysztof

Katarzyna

Łukasz

(2022). “It’ll never be safe, but you can limit the Harms”. Exploring adolescents’ strategies to reduce harms associated with psychoactive substance use. Substance use & Misuse, 57(3), 380–391. https://doi.org/10.1080/10826084.2021.2012694

32.

Jenkins

Slemon

Morris

Hyshka

Schulz

Haines-Saah

R. J.

(2021). Bereaved mothers’ engagement in drug policy reform: A multisite qualitative analysis. International Journal of Drug Policy, 91, Article 103011. https://doi.org/10.1016/j.drugpo.2020.103011

33.

Jenkins

E. K.

Slemon

Haines-Saah

R. J.

(2017). Developing harm reduction in the context of youth substance use: Insights from a multi-site qualitative analysis of young people’s harm minimization strategies. Harm Reduction Journal, 14(1), Article 53. https://doi.org/10.1186/s12954-017-0180-z

34.

Jenkins

E. K.

Slemon

Haines-Saah

R. J.

Oliffe

(2018). A guide to multisite qualitative analysis. Qualitative Health Research, 28(12), 1969–1977. https://doi.org/10.1177/1049732318786703

35.

Jensen

Forlini

Partridge

Hall

(2016). Australian university students’ coping strategies and use of pharmaceutical stimulants as cognitive enhancers. Frontiers in Psychology, 7, Article 277. https://doi.org/10.3389/fpsyg.2016.00277

36.

Kawano

Matsuoka

Takishita

Omae

(1998). Effects of magnesium supplementation in hypertensive patients: Assessment by office, home, and ambulatory blood pressures. Hypertension, 32(2), 260–265. https://doi.org/10.1161/01.hyp.32.2.260

37.

Kecojevic

Corliss

H. L.

Lankenau

S. E.

(2015). Motivations for prescription drug misuse among young men who have sex with men (YMSM) in Philadelphia. International Journal of Drug Policy, 26(8), 764–771. https://doi.org/10.1016/j.drugpo.2015.03.010

38.

Kim

S. J.

Marsch

L. A.

Hancock

J. T.

Das

A. K.

(2017). Scaling up research on drug abuse and addiction through social media big data. Journal of Medical Internet Research, 19(10), Article e353. https://doi.org/10.2196/jmir.6426

39.

Kooij

J. J. S.

Bijlenga

Salerno

Jaeschke

Bitter

Balazs

Thome

Dom

Kasper

Nunes Filipe

Stes

Mohr

Leppamaki

Casas

Bobes

McCarthy

J. M.

Richarte

Kjems Philipsen

Pehlivanidis

Asherson

(2019). Updated European consensus statement on diagnosis and treatment of adult ADHD. European Psychiatry, 56(1), 14–34. https://doi.org/10.1016/j.eurpsy.2018.11.001

40.

Krawczyk

Miller

E. Y.

Irvine

Ramirez

Santaella-Tenorio

Lippincott

Bogenschutz

Bunting

A. M.

Meacham

M. C.

(2025). Self-reported experiences and perspectives on using psychedelics to manage opioid use among participants of two Reddit communities. Addiction. https://doi.org/10.1111/add.16767

41.

Lea

Amada

Jungaberle

(2020). Psychedelic microdosing: A subreddit analysis. Journal of Psychoactive Drugs, 52(2), 101–112. https://doi.org/10.1080/02791072.2019.1683260

42.

LeCocq

M. R.

Randall

P. A.

Besheer

Chaudhri

(2020). Considering drug-associated contexts in substance use disorders and treatment development. Neurotherapeutics, 17(1), 43–54. https://doi.org/10.1007/s13311-019-00824-2

43.

McKetin

Dean

O. M.

Turner

Kelly

P. J.

Quinn

Lubman

D. I.

Dietze

Carter

Higgs

Baker

A. L.

(2019). A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine (“ice”) dependence. Trials, 20(1), 1–11. https://doi.org/10.1186/s13063-019-3450-0

44.

Moore

Fraser

(2006). Putting at risk what we know: Reflecting on the drug-using subject in harm reduction and its political implications. Social Science & Medicine, 62(12), 3035–3047. https://doi.org/10.1016/j.socscimed.2005.11.067

45.

Motta-Ochoa

Bertrand

Arruda

Jutras-Aswad

Roy

(2017). “I love having benzos after my coke shot”: The use of psychotropic medication among cocaine users in downtown Montreal. International Journal of Drug Policy, 49, 15–23. https://doi.org/10.1016/j.drugpo.2017.07.012

46.

Nguyen

T. T.

Tran

M. T. N.

G. M.

Jauffret-Roustide

(2022). Drug harm reduction in Vietnam: A review of stakeholders’ perspectives and implications for future interventions. American Journal of Public Health, 112(S2), S182–S190. https://doi.org/10.2105/AJPH.2022.306764

47.

Oliveira

L. G.

Ponce Jde

Nappo

S. A.

(2010). Crack cocaine use in Barcelona: A reason of worry. Substance Use & Misuse, 45(13), 2291–2300. https://doi.org/10.3109/10826081003682883

48.

Patel

(2020). Reddit claims 52 million daily users, revealing a key figure for social-media platforms. Wall Street Journal. https://www.wsj.com/articles/reddit-claims-52-million-daily-users-revealing-a-key-figure-for-social-media-platforms-11606822200

49.

pistocop. (2022). subreddit-comments-dl. https://github.com/pistocop/subreddit-comments-dl

50.

Pop

I. A.

Gielens

Kottmann

Achterberg

(2024). Exploring the discourses around microdosing psychedelics within the r/microdosing online community. Social Science & Medicine, 347(C), 116702. https://doi.org/10.1016/j.socscimed.2024.116702

51.

Rigg

K. K.

Ibanez

G. E.

(2010). Motivations for non-medical prescription drug use: A mixed methods analysis. Journal of Substance Abuse Treatment, 39(3), 236–247. https://doi.org/10.1016/j.jsat.2010.06.004

52.

Sharifimonfared

Hammersley

(2020). Harm reduction and quitting techniques used by heavy MDMA (ecstasy) users. Addiction Research & Theory, 28(3), 222–230. https://doi.org/10.1080/16066359.2019.1622684

53.

Silva

Kecojevic

Lankenau

S. E.

(2013). Perceived drug use functions and risk reduction practices among high-risk nonmedical users of prescription drugs. Journal of Drug Issues, 43(4), 483–496. https://doi.org/10.1177/0022042613491099

54.

Smith

T. E.

Martel

M. M.

DeSantis

A. D.

(2017). Subjective report of side effects of prescribed and nonprescribed psychostimulant use in young adults. Substance Use & Misuse, 52(4), 548–552. https://doi.org/10.1080/10826084.2016.1240694

55.

Span

Farah

Ivetìc

Stronach

(2024). A scoping review of Australian literature on people who use MDMA and their harm reduction practices. Contemporary Drug Problems, 51(1), 25–44. https://doi.org/10.1177/00914509231214342

56.

Substance Abuse and Mental Health Services Administration. (2016). National survey on drug use and health: detailed tables. Cent Behav Stat Qual, 2017.

57.

Valente

P. K.

Bazzi

A. R.

Childs

Salhaney

Earlywine

Olson

Biancarelli

D. L.

Marshall

B. D.

Biello

K. B.

(2020). Patterns, contexts, and motivations for polysubstance use among people who inject drugs in non-urban settings in the US northeast. International Journal of Drug Policy, 85(Nov), 102934. https://doi.org/10.1016/j.drugpo.2020.102934

58.

Van Schipstal

Mishra

Berning

Murray

(2016). Harm reduction from below: On sharing and caring in drug use. Contemporary Drug Problems, 43(3), 199–215. https://doi.org/10.1177/0091450916663248

59.

Vrecko

(2013). Just how cognitive is “cognitive enhancement”? On the significance of emotions in university students’ experiences with study drugs. AJOB neuroscience, 4(1), 4–12. https://doi.org/10.1080/21507740.2012.740141

60.

Weyandt

L. L.

Oster

D. R.

Marraccini

M. E.

Gudmundsdottir

B. G.

Munro

B. A.

Zavras

B. M.

Kuhar

(2014). Pharmacological interventions for adolescents and adults with ADHD: Stimulant and nonstimulant medications and misuse of prescription stimulants. Psychol Res Behav Manag, 7, 223–249. https://doi.org/10.2147/PRBM.S47013

61.

Wilkerson

J. M.

Noor

S. W.

Breckenridge

E. D.

Adeboye

A. A.

Rosser

B. S.

(2015). Substance-use and sexual harm reduction strategies of methamphetamine-using men who have sex with men and inject drugs. AIDS care, 27(8), 1047–1054. https://doi.org/10.1080/09540121.2015.1020280

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.02 MB